· Intro
· Absorption
· Distribution
· Metabolism
· Excretion
Definition |
· Kidney damage or dysfunction of any cause for ≥3/12 |
Staging by GFR |
1. >90mL/min 2. 60-90 3. 30-60 4. 15-30 5. <15 or dialysis-dependent (= failure) |
Implications |
· Disturbs all aspects of pharmacokinetics · Unpredictable drug behaviour ->> titrate to effect ± ↓dose ± ↓frequency |
Risk factors for toxicity |
· Severe ↓GFR · Renal clearance of parent or active/toxic metabolite · Low therapeutic index
|
Oral |
· ↑Urea -> delayed gastric emptying ->> Risk of dose stacking (e.g. PO metoprolol) |
Inhaled |
· Volatile uptake unaffected |
SC / IM / topical |
· ↑TBW -> oedema -> ↑diffusion distance -> ↓rate of onset · ±Cardiorenal syndrome -> ↓blood flow -> ↓rate of onset ->> Risk of dose stacking (e.g. GTN patch, IM ephedrine) |
Volume of distribution |
·
↑ECF volume -> ↑VD water-soluble
drugs -> ↑loading dose |
Acid-base |
· ±Metabolic acidosis o ↑unionised % of acidic drugs (e.g. thiopentone -> CVS toxicity) o ↓unionised % of basic drugs (e.g. morphine -> ↓effect) |
Plasma proteins |
Important for highly bound drugs. · ↓Albumin -> ↑free acidic drug (e.g. diazepam -> CNS depression) · ↑AAG -> ↓free basic drug (e.g. morphine -> ↓effect) |
Hepatic |
· Urea -> inhibition of CYP enzymes (e.g. fentanyl -> ↑duration) · ±Hepatorenal syndrome |
Renal |
· ↓Drug metabolism (e.g. insulin -> ↑duration) |
Renal |
Renal drug clearance ∝ GFR: · Parent: e.g. pancuronium -> ↑↑duration) prefer atracurium · Active metabolite: e.g. M6G -> opioid toxicity (prefer fentanyl) · Toxic metabolite: e.g. norpethidine -> seizure (prefer fentanyl) |
Haemodialysis |
Variable clearance: · Small, unbound particles cleared-> give after dialysis · Large, bound drugs unaffected -> same schedule Normalisation of TBW: · ↓VD water-soluble drugs |
Feedback welcome at ketaminenightmares@gmail.com